Comparison of the rate of detecting prostate cancer and the pathologic characteristics of the patients with a serum PSA level in the range of 3.0 to 4.0ng/ml and the patients with a serum PSA level in the range 4.1 to 10.0ng/ml

Korean Journal of Urology

Volumn 47, Issue 4, 2006, Pages 358-361

  Park, Hyoung Keun ^a   Hong, Sung Kyu ^b   Byun, Seok Soo ^b   Lee, Sang Eun ^b  

^a Dongguk University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Biopsy; Prostate cancer; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER INCIDENCE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KOREA; MAJOR CLINICAL STUDY; MALE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; REFERENCE VALUE; STATISTICAL SIGNIFICANCE; TRANSRECTAL ULTRASONOGRAPHY;

EID: 33745615814     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2006.47.4.358     Document Type: Article

References (9)

1. Catalona WJ, Smith DS, Ornstein DK. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA 1997;277: 1452-5
2. Babaian RJ, Fritsche H, Ayala A, Bhadkamkar V, Johnston DA, Naccarato W, et al. Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0ng/ml. Urology 2000;56:1000-6
3. Schroder FH, Roobol-Bouts M, Vis AN, Van der Kwast T, Kranse R. Prostate-specific antigen-based early detection of prostate cancer validation of screening without rectal examination. Urology 2001;57:83-90
4. Allan RW, Sanderson H, Epstein JI. Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density. J Urol 2003;170:370-2
5. Kobayashi T, Nishizawa K, Ogura K, Mitsumori K, Ide Y. Detection of prostate cancer in men with prostate-specific antigen levels of 2.0 to 4.0ng/ml equivalent to that in men with 4.1 to 10.0ng/ml in a Japanese population. Urology 2004;63: 727-31
6. Song JM, Kim CB, Chung HC, Kane RL. Prostate-specific antigen, digital rectal examination and transrectal ultrasonography: a meta-analysis for this diagnostic triad of prostate cancer in symptomatic Korean men. Yonsei Med J 2005;46: 414-24
7. Lee DH, Yang WJ, Chung BH, Kim SI, Kim SJ, Kim YS, et al. A multicenter study of the detection rate for prostate cancer according to the serum prostate-specific antigen level in Korean men. Korean J Urol 2005;46:433-7
8. Park HK, Byun SS, Sohn DW, Hong SK, Lee E, Lee SE, et al. The efficacy of 12-site biopsy protocol in men with elevated serum prostate-specific antigen level only. Korean J Urol 2005;46:463-6
9. Schroder FH, van der Cruijsen-Koeter I, de Koning HJ, Vis AN, Hoedemaeker RF, Kranse R. Prostate cancer detection at low prostate specific antigen. J Urol 2000;163:806-12